623P
PEPTIVET 4 OTOLOGICAL SOLUTION 50 ML
PEPTIVET 4 OTOLOGICAL SOLUTION 50 ML
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Peptivet 4
Solution
otological
DescriptionEudermic otological solution to support the reduction of bacterial and Malassezia growth during otitis media in dogs and cats.
- As a first approach in the course of otitis media due to bacterial overgrowth and/or Malassezia.
- In subjects who tend to have relapses.
How to use
1. Shake before use.
2. Apply Peptivet 4 into the ear canal twice daily as needed or as directed by your veterinarian.
3. Gently massage the base of the external ear canal to allow adequate distribution of the product inside it and promote its action.
4. Periodic use of the product helps to prolong the time interval between potential relapses.
Conservation
Store at room temperature.
Shelf life when packaging is intact: 36 months.
Format
50 ml bottle.
Cod. PP3930001
623P
PEPTIVET 4 OTOLOGICAL SOLUTION 50 ML
PEPTIVET 4 OTOLOGICAL SOLUTION 50 ML
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
